tiprankstipranks
PolyPid enrolls 100th patient in SHIELD II phase 3 trial
PremiumThe FlyPolyPid enrolls 100th patient in SHIELD II phase 3 trial
2M ago
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
PremiumPress Releases
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
2M ago
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
2M ago
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
PremiumPress ReleasesPolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
6M ago
PolyPid appoints Nurit Tweezer-Zaks to board of directors
PremiumThe Fly
PolyPid appoints Nurit Tweezer-Zaks to board of directors
6M ago
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
PremiumPress Releases
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
6M ago
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
PremiumPress ReleasesPolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
7M ago
PolyPid announces publication of preclinical data on D-PLEX100
PremiumThe Fly
PolyPid announces publication of preclinical data on D-PLEX100
7M ago
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
PremiumPress Releases
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100